biomed
research
human
be
larg
restrict
vitro
studi
lack
complex
live
organ
overcom
limit
human
mous
model
develop
base
immunodefici
characterist
sever
combin
immunodefici
scid
recombin
activ
gene
rag
null
mice
accept
xenograft
peripher
constitut
human
immun
scid
rag
null
mice
achiev
transplant
matur
human
immun
cell
foetal
human
thymu
bone
marrow
liver
tissu
lymph
node
combin
although
effici
need
improv
mous
model
constitut
human
immun
defin
human
mice
present
text
wide
use
investig
basic
principl
human
immunobiolog
well
complex
pathomechan
potenti
therapi
human
diseas
element
ideal
human
mous
model
highlight
includ
genet
nongenet
modif
recipi
mice
transplant
strategi
propos
improv
engraft
applic
human
mice
studi
develop
respons
human
immun
cell
human
autoimmun
diseas
viru
infect
transplant
biolog
tumour
biolog
review
well
studi
human
immunobiolog
vivo
limit
technic
ethic
constraint
anim
model
human
immun
system
would
significantli
advanc
understand
human
immunobiolog
immunerel
diseas
autoimmun
diseas
viru
infect
well
tumour
graft
reject
immunodefici
mice
constitut
human
immun
develop
overcom
constraint
import
research
tool
vivo
studi
human
haematolymphopoiesi
immun
respons
sever
combin
immunodefici
scid
recombin
activ
gene
rag
null
mice
lack
b
cell
origin
use
recipi
rebuild
human
immun
recent
genet
modifi
scid
rag
null
mice
includ
scidbeig
nonobes
diabeticsever
combin
immunodefici
nodscid
null
null
scid
mice
defect
dna
repair
mutat
dnadepend
protein
kinas
dnapk
inbr
mous
strain
therefor
lack
product
rearrang
cell
receptor
immunoglobulin
gene
subsequ
result
defici
b
cell
lack
function
b
cell
scid
mice
contribut
accept
allogen
xenogen
graft
without
sever
reject
howev
scid
mice
radiat
repair
defici
uncomplet
block
vdj
recombin
old
scid
mice
may
becom
leaki
mice
depend
antigen
stimul
fig
addit
residu
innat
immun
includ
complement
natur
killer
nk
cell
macrophag
granulocyt
remain
somewhat
intact
scid
mice
may
limit
graft
effici
xenogen
cell
tissu
null
mice
creat
impair
chain
nodscid
mice
mice
complet
defect
b
nk
activ
moreov
dendrit
cell
dc
becom
function
defect
null
mice
result
reduct
product
therefor
null
mice
current
consid
optim
recipi
human
hsc
complet
defici
adapt
immun
impair
innat
immun
fig
respons
initi
tcr
immunoglobulin
gene
vdj
rearrang
gener
dna
doubl
strand
break
therefor
homozyg
mutant
mice
result
inabl
produc
matur
b
cell
lead
scidlik
phenotyp
mice
becom
leaki
age
due
complet
inabl
initi
vdj
recombin
display
longer
life
span
nodltszscid
mice
due
delay
prevent
thymic
lymphoma
associ
dna
repair
defect
fig
howev
could
support
effici
human
engraft
function
innat
immun
fig
fig
thu
frequenc
leaki
immunodefici
mice
follow
descend
order
null
mice
null
null
mice
null
pfp
null
mice
null
mice
rag
null
mice
nodscid
mice
scid
mice
fig
favour
mous
recipi
graft
human
haematopoiet
immun
cell
gener
follow
null
mice
null
null
mice
null
pfp
null
mice
nodscid
mice
null
mice
scid
mice
rag
null
mice
fig
combin
protocol
show
margin
effect
function
distribut
transfer
human
pbl
lymph
organ
model
consid
anoth
weak
model
weak
primari
immun
respons
howev
induc
substanti
immun
respons
recipi
mous
xenoantigen
skew
human
lymphoid
repertoir
xenorespons
mediat
human
b
cell
caus
potenti
fatal
gvhd
also
sever
limit
abil
human
pbl
respond
exogen
antigen
thu
applic
approach
biomed
research
current
somewhat
limit
human
bone
marrow
graft
scid
mice
histolog
compar
normal
foetal
bone
marrow
fragment
foetal
human
femur
tibia
implant
scid
mice
model
human
cell
popul
present
circul
consist
mostli
b
cell
cell
belong
monocyticgranulocyt
lineag
human
igm
igg
occasion
ige
detect
sera
matur
human
cell
could
observ
bone
circul
mice
multilineag
reconstitut
function
b
nk
cell
achiev
irradi
null
mice
transplant
human
hsc
without
cotransplant
human
immun
tissu
human
cell
develop
thymu
mice
migrat
peripher
lymphoid
organ
cell
bear
polyclon
respond
mitogen
stimuli
pha
also
allogen
human
cell
result
indic
function
human
cell
could
reconstitut
null
mice
graft
human
cell
human
cord
blood
cell
inject
nodscid
foetus
human
immun
cell
could
effici
selfrenew
differenti
foetal
mous
environ
although
multilineag
engraft
occur
foetal
recipi
frequenc
level
engraft
lower
previous
report
human
immun
cell
transplant
adult
nodscid
recipi
like
null
mice
null
null
mice
engraft
human
cord
blood
cell
led
multilineag
human
haematopoiesi
product
cell
b
cell
dc
primari
secondari
lymphoid
organ
thymu
bone
marrow
spleen
lymph
node
reconstitut
mice
human
immun
cell
human
immun
respons
demonstr
mice
immun
tetanu
toxoid
infect
epsteinbarr
viru
ebv
low
level
antigenspecif
human
igg
product
upon
immun
indic
ineffici
class
switch
present
model
addit
level
human
cell
mice
much
lower
compar
human
mice
receiv
human
foetal
thymu
tissu
suggest
poor
efficaci
human
thymopoiesi
xenogen
mous
thymu
may
exist
anoth
import
approach
establish
human
mous
model
transplant
foetal
human
thymu
liver
tissu
beneath
kidney
capsul
scid
mice
result
develop
well
vascular
human
thymuslik
organ
despit
larg
number
human
cell
present
thymu
level
peripher
circul
human
cell
rel
low
model
human
cell
respons
mitogen
stimuli
alloantigen
produc
type
amount
cytokin
similar
compart
human
be
howev
detect
matur
human
b
cell
gener
mice
increas
quantiti
implant
foetal
human
thymu
liver
tissu
somehow
enhanc
percentag
human
cell
peripher
blood
spleen
lymph
node
structur
bone
thymu
indistinguish
agematch
human
counterpart
mice
produc
human
igm
igg
level
consist
higher
observ
scid
mice
graft
human
thymu
liver
tissu
donor
furthermor
four
human
igg
subclass
iga
ige
detect
result
show
human
antibodi
product
isotyp
switch
occur
mice
indic
human
apc
b
cell
interact
physiolog
respons
environment
antigen
importantli
cotransplant
human
foetal
thymusliv
tissu
hsc
led
effici
establish
human
haematopoiesi
function
immun
system
nodscid
mice
show
repopul
multilineag
human
haematopoiet
cell
includ
cell
b
cell
dc
secondari
lymphoid
tissu
mice
produc
high
level
human
igm
igg
antibodi
mediat
strong
immun
respons
vivo
demonstr
skin
xenograft
reject
human
mice
provid
power
model
studi
human
immun
function
vivo
optim
experiment
human
mous
model
human
immun
cell
lineag
develop
home
specif
site
perform
optim
immun
respons
explor
therefor
combin
modifi
recipi
immunodefici
athym
avail
space
proper
microenviron
includ
growth
factor
home
molecul
transplant
strategi
human
immun
tissu
stem
cell
would
creat
optim
human
mous
model
approxim
complet
human
immun
system
tabl
repertoir
thymocyt
graft
compar
foetal
thymu
transplant
demonstr
gener
human
cell
divers
human
thymu
graft
human
cell
matur
human
thymu
graft
respond
toxic
shock
syndrom
superantigen
ebv
infect
mitogen
indic
function
recent
studi
also
show
human
cell
could
effici
devel
human
antigenspecif
immunoglobulin
produc
immun
cellindepend
antigen
human
dc
human
mice
development
phenotyp
function
similar
dc
subset
found
human
be
human
nk
cell
mainli
repopul
bm
spleen
show
cytotox
cell
model
human
pbl
obtain
patient
organspecif
multisystem
autoimmun
diseas
surviv
scid
mice
sever
month
produc
igg
autoantibodi
specif
found
donor
therefor
provid
possibl
way
investig
pathogenesi
effector
phase
human
autoimmun
diseas
vivo
model
scid
mice
circul
antipemphigu
antibodi
found
mice
human
igg
deposit
traumat
skin
allogen
human
skin
graft
scid
mice
reconstitut
patient
pbl
develop
pvlike
lesion
contain
human
igg
deposit
result
indic
human
mice
may
serv
model
antibodymedi
human
autoimmun
skin
diseas
scid
mice
graft
human
pbl
hiv
infect
limit
short
period
cell
rapidli
deplet
lack
replenish
sourc
intrasplen
transfer
pbl
untreat
hivinfect
patient
nodscid
mice
strong
hivspecif
antibodi
respons
observ
therefor
feasibl
studi
hivspecif
human
humour
immun
respons
isol
human
mab
hiv
human
mice
graft
human
thymu
liver
tissu
hiv
infect
show
preferenti
tropism
popul
intrathym
progenitor
cell
thymocyt
normal
gener
transplant
human
cb
cell
longlast
viremia
infect
isol
detect
spleen
bone
marrow
thymi
null
mice
also
high
rate
viral
infect
accompani
product
env
gag
antibodi
human
null
null
mice
construct
cord
blood
cell
express
human
cell
lymphoid
organ
close
resembl
hiv
coreceptor
express
human
be
human
mous
model
develop
preclin
evalu
antivir
compound
hiv
includ
azidothymidin
dideoxyinosin
dideoxycytosin
nevirapin
proteas
inhibitor
nonimmunosuppress
cyclosporin
deriv
peptid
inhibitor
interact
zincfing
inhibitor
human
mice
construct
human
thymu
liver
tissu
lymph
node
permiss
hiv
replic
antivir
compound
azidothymidin
would
partial
suppress
replic
timeand
dosedepend
manner
exposur
cocain
enhanc
hiv
infect
vivo
activ
receptor
modul
express
hiv
coreceptor
select
antagonist
block
effect
cocain
hiv
replic
scid
mice
graft
human
pbl
addit
human
mous
model
also
proven
use
evalu
gene
therapeut
approach
transfer
human
cell
contain
retrovir
vector
drastic
reduc
preexist
hiv
infect
enhanc
cell
surviv
well
cytokin
express
sar
kind
corona
viru
caus
deadli
epidem
asia
human
mice
construct
human
pbl
use
studi
novel
vaccin
candid
sar
cov
sar
dna
vaccin
induc
human
cytotox
lymphocyt
specif
sar
antigen
human
neutral
antibodi
sar
cov
demonstr
angiotensinconvert
enzym
function
receptor
sar
cov
vzv
appear
caus
viremia
infect
human
lymphocyt
human
mous
model
use
examin
vzv
pathogenesi
immunobiolog
vivo
experi
provid
evid
support
critic
role
cell
tropism
vzv
pathogenesi
elimin
kinas
activ
impair
viru
product
envelop
would
block
vzv
infect
cell
dengu
viru
import
mosquitoborn
flaviviru
infect
human
be
caus
rang
ill
subclin
infect
acut
dengu
fever
sever
dengu
haemorrhag
feverdengu
shock
syndrom
major
limit
understand
dengu
viru
pathogenesi
immun
lack
ideal
human
anim
model
irradi
nodscid
null
null
mice
graft
human
cord
blood
haematopoiet
progenitor
cell
foetal
liverderiv
cell
achiev
replic
dengu
viral
infect
physiolog
set
model
found
suscept
dengu
viru
infect
show
sign
typic
fever
thrombocytopenia
use
evalu
dengu
viru
pathogenesi
also
human
mice
use
investig
pathogenesi
therapeut
ebv
cytomegaloviru
cmv
influenza
infect
pig
may
suitabl
donor
human
xenotransplant
potenti
transmiss
perv
human
cell
investig
human
mice
tissu
posit
perv
dna
howev
infect
nonproduct
perv
transcript
detect
tissu
might
due
microchimer
pseudotyp
murin
virus
importantli
shown
human
cell
porcin
cell
could
coexist
mani
week
without
evid
infect
human
cell
perv
nodscid
mice
transgen
certain
porcin
cytokin
transplant
porcin
bmc
human
foetal
thymu
liver
tissu
howev
remain
seen
whether
immunosuppress
therapi
would
facilit
retrovir
infect
human
cell
transplant
allogen
hlamismatch
foetal
pancreas
scid
mice
graft
human
thymu
liver
tissu
pbl
result
infiltr
human
mononuclear
cell
pancrea
subsequ
reject
human
cell
respons
reject
skin
transplant
allogen
donor
scid
mice
like
skin
graft
perform
among
human
be
dermal
microvessel
destroy
skin
becam
necrot
scid
mice
graft
human
pbl
establish
model
delayedtyp
hypersensit
dth
human
skin
graft
onto
back
autolog
human
immun
cell
inject
periton
caviti
scid
mice
inject
tetanu
toxoid
human
skin
graft
adjac
mous
skin
caus
perivascular
human
cell
infiltr
indic
human
cell
specif
recogn
human
mous
skin
home
site
human
cell
respons
depend
human
microenviron
recent
found
adapt
treg
cell
isol
kidney
transplant
recipi
toler
donor
mediat
suppress
donorspecif
dth
human
scid
mice
scid
mice
transplant
human
foetal
liver
donor
foetal
thymu
donor
b
develop
mix
chimer
human
thymu
model
human
cell
reactiv
donor
clonal
delet
select
thymu
cell
potenti
respond
donor
b
render
anerg
upon
interact
allogen
thymic
epitheli
cell
donor
b
demonstr
spleen
liver
lung
kidney
bone
marrow
recipi
deplet
treg
cell
human
pbmc
significantli
exacerb
xenogen
gvhd
wherea
coadministr
subset
treg
cell
significantli
inhibit
expans
effector
cell
reduc
lethal
xenogen
gvhd
interestingli
protect
role
associ
signific
increas
plasma
level
indic
de
novo
develop
cell
human
mous
model
use
studi
immun
respons
xenogen
porcin
graft
vivo
circul
human
cell
mice
infiltr
pig
skin
arteri
graft
contrast
robust
immun
respons
allogen
human
cell
vitro
howev
tnftreat
pig
tissu
permit
human
cell
infiltr
injur
pig
skin
arteri
graft
action
proinflammatori
cytokin
speciesrestrict
could
activ
pig
endotheli
cell
express
cell
surfac
molecul
necessari
recruit
local
infiltr
leucocyt
thu
addit
tnf
human
mice
might
use
studi
primari
human
cellmedi
antiporcin
xenogen
respons
vivo
porcin
thymu
graft
scid
mice
graft
foetal
porcin
thymu
human
liver
tissu
support
normal
develop
polyclon
function
human
cell
haematopoiet
precursor
provid
human
foetal
liver
cell
human
cell
specif
toler
donor
porcin
antigen
normal
respond
nondonor
porcin
xenoantigen
alloantigen
exogen
abolish
toler
suggest
central
clonal
delet
rather
anergi
possibl
toler
mechan
recent
human
cell
develop
chimer
show
specif
nonrespons
porcin
donor
lack
reject
porcin
haematopoiet
cell
antidonor
pig
mlr
respons
well
accept
donor
swine
leucocyt
antigen
sla
match
skin
graft
wherea
human
cell
mix
chimer
mice
reject
third
parti
porcin
skin
graft
respond
third
parti
pig
allogen
human
antigen
mlr
assay
capac
haematopoiet
chimer
induc
cell
toler
donor
cell
larg
result
intrathym
clonal
delet
matur
donorreact
thymocyt
malign
tumour
unlimitedli
grow
escap
human
immun
surveil
athym
nude
mice
scid
rag
mice
could
success
engraft
xenogen
human
tumour
includ
wide
varieti
solid
human
tumour
haematolog
neoplasm
human
tumour
biolog
growth
angiogenesi
metastasi
evalu
abil
engraft
human
tumour
human
immunocompet
cell
success
immunodefici
mice
spawn
develop
use
human
mous
model
evalu
antitumour
therapi
studi
tumour
biolog
human
be
imped
access
tissu
site
tumour
growth
well
ethic
concern
inde
ideal
model
human
mice
complet
human
immun
system
permit
evalu
mechan
tumour
immunobiolog
context
intact
human
immun
microenviron
human
mice
use
evalu
therapeut
approach
inhibit
human
tumour
growth
includ
use
angiogenesi
inhibitor
cellbas
therapi
human
antibodi
tradit
immunosuppress
immunotherapeut
protocol
tumourgrowth
inhibitor
human
mice
provid
opportun
evalu
human
cytokin
chemokin
augment
innat
adapt
antitumour
immun
respons
human
leucocyt
thu
provid
model
clinic
relev
model
util
test
antitumour
efficaci
wide
spectrum
human
cytokin
cytokinedeliveri
strategi
includ
direct
inject
solubl
cytokin
cytokin
gene
transfer
use
slowreleas
polym
particl
human
mous
model
made
tremend
progress
modif
recipi
mice
transplant
strategi
recent
year
model
becom
power
versatil
tool
investig
human
haematolymphoid
differenti
autoimmun
viru
infect
transplant
reject
toler
induct
howev
much
effort
direct
minim
innat
immun
mediat
nk
cell
macrophag
scid
rag
null
mous
recipi
incompat
cytokin
adhes
molecul
mice
human
be
could
descend
human
immun
cell
level
immunodefici
recipi
immunodefici
mice
import
human
growth
factor
ideal
recipi
establish
human
mice
optim
human
mous
model
offer
power
approach
us
studi
human
immun
vivo
significantli
advanc
biomed
research
